|
|
 |
|
Total Number of Holdings (excluding cash): 51
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$44,304.00 |
2.43% |
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$43,455.80 |
2.38% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$42,150.33 |
2.31% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$40,203.90 |
2.21% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$40,178.00 |
2.20% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$39,885.46 |
2.19% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$39,783.20 |
2.18% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$39,029.38 |
2.14% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,547.36 |
2.11% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$38,421.04 |
2.11% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$38,025.00 |
2.09% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$38,170.25 |
2.09% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$38,123.81 |
2.09% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$37,970.70 |
2.08% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$38,003.94 |
2.08% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$37,486.33 |
2.06% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$37,285.50 |
2.05% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$37,456.97 |
2.05% |
| Steris Plc |
STE |
G8473T100 |
173 |
$36,788.45 |
2.02% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$36,634.60 |
2.01% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$36,653.85 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$36,327.50 |
1.99% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$36,296.40 |
1.99% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$36,235.80 |
1.99% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$36,368.28 |
1.99% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$36,182.76 |
1.98% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$36,175.35 |
1.98% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$36,148.31 |
1.98% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$36,057.90 |
1.98% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$35,964.35 |
1.97% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$35,924.82 |
1.97% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$35,661.60 |
1.96% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$35,706.00 |
1.96% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$35,816.17 |
1.96% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$35,447.02 |
1.94% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$35,371.80 |
1.94% |
| Waters Corporation |
WAT |
941848103 |
121 |
$35,347.73 |
1.94% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$35,162.05 |
1.93% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$35,081.54 |
1.92% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$35,089.19 |
1.92% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$34,708.68 |
1.90% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$34,679.50 |
1.90% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$34,526.36 |
1.89% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$34,139.94 |
1.87% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$33,246.28 |
1.82% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$33,148.98 |
1.82% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$31,348.61 |
1.72% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$31,363.92 |
1.72% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$29,086.30 |
1.60% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$20,303.31 |
1.11% |
| US Dollar |
$USD |
|
7,572 |
$7,571.75 |
0.42% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|